#Canada; #JustinTrudeau; #CanadaInvestment; #Vancouver; #BC; #AbCelleraBiologicsInc.; #Covid19Research
Ottawa, May 4 (Canadian-Media): An investment of $175 million was announced by Canada's Prime Minister Justin Trudeau during his daily news conference in Ottawa Sunday, to support Vancouver-based AbCellera Biologics Inc's research on COVID-19 pandemic, media reports said.
Justin Trudeau. Image credit: pm.gc.ca
Promising signs of progress was revealed by AbCellera Biologics Inc.'s identification of antibodies that could be used to create a treatment for COVID-19, said Trudeau.
“Each and every one of us is affected, and our teams stand together, galvanized to fight this outbreak,” said Carl Hansen, Ph.D., CEO of AbCellera. “We are proud to have the support of the Government of Canada to quickly find solutions to the COVID-19 pandemic.”
AbCellera, a privately held Canadian biotech with a drug discovery platform engaged in search of antibodies that can be used to prevent and treat diseases, is also receiving support from the City of Vancouver.
“The City of Vancouver is fully committed to ensuring AbCellera has the infrastructure needed as they accelerate finding a treatment for COVID-19,” said City of Vancouver's Mayor Kennedy Stewart on May 3. “We couldn’t be more proud to be on the front lines of this global effort thanks to the innovation and leadership of AbCellera.”
Federal government is also investing $240 million to boost access to online health services, including virtual access to doctors for primary care, and mental-health support.